Literature DB >> 3035103

Congenital Lambert-Eaton myasthenic syndrome.

B Bady, G Chauplannaz, H Carrier.   

Abstract

A 4 year old girl had been hypotonic and areflexic since birth with delayed milestones in motor development. Repetitive stimulation at high rates performed at 3 years elicited an incremental response typical of the Lambert-Eaton Syndrome.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3035103      PMCID： PMC1031886          DOI： 10.1136/jnnp.50.4.476

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  6 in total

1.  A myasthenic syndrome in childhood leukemia.

Authors:  Y Shapira; G Cividalli; G Szabo; R Rozin; A Russell
Journal:  Dev Med Child Neurol       Date:  1974-10       Impact factor: 5.449

2.  Eaton-Lambert syndrome in a 9-year-old girl.

Authors:  E Chelmicka-Schorr; L P Bernstein; E B Zurbrugg; P R Huttenlocher
Journal:  Arch Neurol       Date:  1979-09

3.  Abnormal neuromuscular transmission in an infantile myasthenic syndrome.

Authors:  J W Albers; J A Faulkner; K Dorovini-Zis; K F Barald; R E Must; R D Ball
Journal:  Ann Neurol       Date:  1984-07       Impact factor: 10.422

4.  Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

Authors:  B Lang; J Newsom-Davis; C Prior; D Wray
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

5.  Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.

Authors:  A Roberts; S Perera; B Lang; A Vincent; J Newsom-Davis
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

6.  Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

Authors:  H Fukunaga; A G Engel; B Lang; J Newsom-Davis; A Vincent
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205
  6 in total
  5 in total

Review 1.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 2.  Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.

Authors:  Kinji Ohno; Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 3.  How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.

Authors:  Paulo José Lorenzoni; Rosana Herminia Scola; Claudia Suemi Kamoi Kay; Lineu Cesar Werneck; Rita Horvath; Hanns Lochmüller
Journal:  Neuromolecular Med       Date:  2018-04-25       Impact factor: 3.843

Review 4.  The spectrum of congenital myasthenic syndromes.

Authors:  Andrew G Engel; Kinji Ohno; Steven M Sine
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

5.  Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports.

Authors:  Simona Portaro; Teresa Brizzi; Stefano Sinicropi; Alberto Cacciola; Maria Cristina De Cola; Alessia Bramanti; Demetrio Milardi; Antonino Lupica; Placido Bramanti; Antonio Toscano; Carmelo Rodolico
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.